Do extraintestinal manifestations predict disease course, severity, and/or activity in IBD?
Walker
David
D
Imperial College, London, UK.
Orchard
Tim
T
D015415:Biomarkers; D015209:Cholangitis, Sclerosing / Q000209:etiology / Q000473:pathology; D018450:Disease Progression; D004893:Erythema Nodosum / Q000209:etiology / Q000473:pathology; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000150:complications* / Q000473:pathology*; D010641:Phenotype; D011237:Predictive Value of Tests; D017511:Pyoderma Gangrenosum / Q000209:etiology / Q000473:pathology; D012720:Severity of Illness Index; D013167:Spondylitis, Ankylosing / Q000209:etiology / Q000473:pathology; D014603:Uveal Diseases / Q000209:etiology / Q000473:pathology
D015415:Biomarkers